National Research Company Insiders
| NRC Stock | USD 12.08 0.75 5.85% |
National Research's insiders are aggressively buying. The analysis of insiders' sentiment of trading National Research Corp stock suggests that all insiders are extremely bullish at this time. National Research employs about 368 people. The company is managed by 19 executives with a total tenure of roughly 15 years, averaging almost 0.0 years of service per executive, having 19.37 employees per reported executive.
| Michael Hays President President, Founder |
Insider Sentiment 100
Aggressively Buying
Selling | Buying |
Latest Trades
| 2025-07-31 | Jordan Nicole Freeman | Acquired 771 @ 12.97 | View | ||
| 2025-05-12 | Patrick E Beans | Acquired 2500 @ 13.59 | View |
Monitoring National Research's insider sentiment can offer insights into its future performance, as insiders often have access to more information about their company's operations, financial health, and upcoming initiatives than the general public. However, it's essential to note that insider trading is regulated by securities laws, and insiders are required to disclose their trades publicly to ensure transparency and prevent unfair advantages based on non-public information.
Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in National Research Corp. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in real. National Research's Workforce Through the Years
Please note that employee historical analysis has become an increasingly important factor for investors assessing the risk associated with National Research's future performance. Based on our forecasts, it is anticipated that National will maintain a workforce of about 370 employees by March 2026.National Research Management Team Effectiveness
The company has Return on Asset of 0.1056 % which means that on every $100 spent on assets, it made $0.1056 of profit. This is way below average. In the same way, it shows a return on shareholders' equity (ROE) of 0.5124 %, implying that it generated $0.5124 on every 100 dollars invested. National Research's management efficiency ratios could be used to measure how well National Research manages its routine affairs as well as how well it operates its assets and liabilities. At present, National Research's Return On Capital Employed is projected to increase slightly based on the last few years of reporting. At present, National Research's Total Current Assets are projected to increase significantly based on the last few years of reporting. The current year's Intangible Assets is expected to grow to about 3.8 M, whereas Total Assets are forecasted to decline to about 84.9 M.As of February 15, 2026, Common Stock Shares Outstanding is expected to decline to about 15.5 M. In addition to that, Net Income Applicable To Common Shares is expected to decline to about 20.5 MNational Research Corp maintains a total of 22.64 Million outstanding shares. National Research Corp holds significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Please note that no matter how many assets the company has, if the real value of the firm is less than the current market value, you may not be able to make money on it.
Shares in Circulation | First Issued 1997-03-31 | Previous Quarter 22.6 M | Current Value 21.8 M | Avarage Shares Outstanding 14.9 M | Quarterly Volatility 8.9 M |
National Research Workforce Comparison
National Research Corp is rated below average in number of employees category among its peers. The total workforce of Health Care industry is now estimated at about 8,926. National Research holds roughly 368 in number of employees claiming about 4% of equities under Health Care industry.
National Research Profit Margins
The company has Net Profit Margin of 0.08 %, which implies that it may need a different competitive strategy as even a very small decline in it revenue may erase profits and result in a net loss. This is way below average. In the same way, it shows Net Operating Margin of 0.13 %, which entails that for every 100 dollars of revenue, it generated $0.13 of operating income.| Current Value | Last Year | Change From Last Year | 10 Year Trend | ||||||
|---|---|---|---|---|---|---|---|---|---|
| Gross Profit Margin | 0.46 | 0.5633 |
|
| |||||
| Net Profit Margin | 0.14 | 0.0844 |
|
| |||||
| Operating Profit Margin | 0.2 | 0.1644 |
|
| |||||
| Pretax Profit Margin | 0.19 | 0.1299 |
|
| |||||
| Return On Assets | 0.0817 | 0.086 |
|
| |||||
| Return On Equity | 0.52 | 0.8292 |
|
|
National Research Insider Trading History
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific National Research insiders, such as employees or executives, is commonly permitted as long as it does not rely on National Research's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases, National Research insiders must file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
| Buy/Sell Ratio | # Purchases Trades | # Sales Trades | Total Shares Purchased | Total Shares Sold | |
|---|---|---|---|---|---|
| 2026-03-01 | 1.0 | 1 | 1 | 9,145 | 9,145 |
| 2025-12-01 | 2.0 | 4 | 2 | 80,221 | 23,590 |
| 2025-03-01 | 0.6667 | 2 | 3 | 21,035 | 22,552 |
| 2024-12-01 | 1.0 | 1 | 1 | 4,755,317 | 4,755,317 |
| 2024-03-01 | 0.1538 | 2 | 13 | 12,163 | 1,329,459 |
| 2023-06-01 | 0.2174 | 5 | 23 | 36,930 | 165,402 |
| 2023-03-01 | 0.4 | 6 | 15 | 94,408 | 144,300 |
| 2022-09-01 | 0.25 | 1 | 4 | 23,581 | 120,113 |
| 2022-06-01 | 0.8571 | 6 | 7 | 72,468 | 282,364 |
| 2022-03-01 | 2.0 | 4 | 2 | 35,410 | 30,227 |
| 2021-12-01 | 0.2308 | 3 | 13 | 41,989 | 292,652 |
| 2021-06-01 | 0.875 | 7 | 8 | 50,089 | 125,842 |
| 2021-03-01 | 0.5833 | 7 | 12 | 85,034 | 4,941,757 |
| 2020-12-01 | 0.5 | 4 | 8 | 119,403 | 222,121 |
| 2020-09-01 | 0.2857 | 4 | 14 | 48,787 | 113,185 |
| 2020-06-01 | 0.7143 | 5 | 7 | 77,625 | 79,891 |
| 2020-03-01 | 0.2609 | 6 | 23 | 114,721 | 252,984 |
| 2019-12-01 | 0.1053 | 2 | 19 | 46,440 | 123,884 |
| 2019-09-01 | 0.0938 | 3 | 32 | 72,843 | 1,002,388 |
| 2019-06-01 | 0.3333 | 4 | 12 | 27,284 | 283,290 |
| 2019-03-01 | 0.2105 | 4 | 19 | 48,010 | 357,120 |
| 2018-09-01 | 0.0408 | 2 | 49 | 72,000 | 420,549 |
| 2018-06-01 | 0.386 | 44 | 114 | 4,343,961 | 4,616,225 |
| 2018-03-01 | 0.4118 | 14 | 34 | 5,568,871 | 7,224,945 |
| 2017-12-01 | 0.1429 | 2 | 14 | 85,757 | 305,737 |
| 2017-09-01 | 0.3333 | 1 | 3 | 2,773 | 5,546 |
| 2017-06-01 | 0.5682 | 25 | 44 | 271,943 | 114,558 |
| 2017-03-01 | 0.7778 | 7 | 9 | 73,851 | 559,938 |
| 2016-06-01 | 4.0 | 12 | 3 | 218,300 | 12,575 |
| 2016-03-01 | 1.4444 | 13 | 9 | 116,938 | 65,491 |
| 2015-12-01 | 1.0 | 6 | 6 | 105,882 | 30,080 |
| 2015-09-01 | 2.0 | 4 | 2 | 965,813 | 689,373 |
| 2015-06-01 | 0.8889 | 8 | 9 | 168,000 | 51,408 |
| 2015-03-01 | 0.3333 | 6 | 18 | 597,491 | 95,476 |
| 2014-12-01 | 0.25 | 3 | 12 | 24,000 | 63,931 |
| 2014-06-01 | 0.8889 | 8 | 9 | 210,000 | 32,595 |
| 2014-03-01 | 1.0667 | 16 | 15 | 383,591 | 238,866 |
| 2013-12-01 | 0.2727 | 6 | 22 | 48,000 | 180,493 |
| 2013-09-01 | 0.2 | 2 | 10 | 6,000 | 769,026 |
| 2013-06-01 | 0.4444 | 4 | 9 | 48,000 | 10,027,432 |
| 2013-03-01 | 0.6 | 3 | 5 | 19,270 | 261,279 |
| 2012-12-01 | 0.36 | 9 | 25 | 336,992 | 562,723 |
| 2012-09-01 | 0.8 | 4 | 5 | 45,500 | 37,845 |
| 2012-06-01 | 0.8333 | 5 | 6 | 50,500 | 25,050 |
| 2012-03-01 | 0.8571 | 6 | 7 | 396,801 | 863,136 |
| 2011-12-01 | 0.6667 | 2 | 3 | 9,461 | 14,408 |
| 2011-09-01 | 1.0 | 2 | 2 | 62,000 | 12,000 |
| 2011-06-01 | 1.6 | 8 | 5 | 262,347 | 19,197 |
| 2011-03-01 | 1.0 | 4 | 4 | 24,143 | 11,686 |
| 2010-12-01 | 0.5 | 5 | 10 | 2,503,000 | 2,509,864 |
| 2010-09-01 | 0.5 | 1 | 2 | 1,000.00 | 839.00 |
| 2010-06-01 | 4.0 | 4 | 1 | 48,000 | 250.00 |
| 2010-03-01 | 0.75 | 6 | 8 | 1,504,368 | 5,017,780 |
| 2009-12-01 | 0.2 | 2 | 10 | 2,000 | 4,553 |
| 2009-06-01 | 0.4 | 4 | 10 | 48,000 | 43,586 |
| 2009-03-01 | 1.5 | 6 | 4 | 31,078 | 525,994 |
| 2008-12-01 | 0.1071 | 3 | 28 | 42,336 | 101,588 |
| 2008-09-01 | 0.44 | 11 | 25 | 45,088 | 79,513 |
| 2008-06-01 | 0.2174 | 5 | 23 | 48,382 | 7,338 |
| 2008-03-01 | 0.5417 | 13 | 24 | 87,314 | 43,298 |
| 2007-12-01 | 0.44 | 11 | 25 | 54,409 | 82,274 |
| 2007-09-01 | 0.7778 | 7 | 9 | 3,398 | 5,546 |
| 2007-06-01 | 0.92 | 23 | 25 | 58,209 | 14,032 |
| 2007-03-01 | 2.3333 | 7 | 3 | 66,872 | 1,335 |
| 2006-12-01 | 0.375 | 27 | 72 | 17,646 | 36,255 |
| 2006-09-01 | 0.5 | 11 | 22 | 4,975 | 10,187 |
| 2006-06-01 | 0.5 | 7 | 14 | 61,427 | 17,796 |
| 2006-03-01 | 0.4857 | 17 | 35 | 72,427 | 54,014 |
| 2005-12-01 | 0.6667 | 2 | 3 | 1,285 | 1,785 |
| 2005-09-01 | 1.0 | 3 | 3 | 3,404 | 3,404 |
| 2005-06-01 | 3.6667 | 11 | 3 | 91,177 | 3,000 |
| 2004-12-01 | 0.6667 | 4 | 6 | 7,794 | 13,494 |
| 2004-09-01 | 1.5 | 3 | 2 | 2,361 | 1,361 |
| 2004-06-01 | 0.5 | 6 | 12 | 11,500 | 18,400 |
| 2004-03-01 | 0.875 | 7 | 8 | 60,287 | 7,442 |
| 2003-12-01 | 1.0 | 2 | 2 | 1,425 | 1,425 |
| 2003-09-01 | 1.0 | 2 | 2 | 1,740 | 1,740 |
National Research Notable Stakeholders
A National Research stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as National Research often face trade-offs trying to please all of them. National Research's stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting National Research's stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
| Trent Green | CEO Director | Profile | |
| Michael Hays | President, Founder | Profile | |
| Shane Harrison | Executive CFO | Profile | |
| Kevin CPA | CFO, Finance | Profile | |
| CPA CPA | CFO, Fin | Profile | |
| Jennifer Baron | Chief Officer | Profile | |
| Gregory MS | Chief Officer | Profile | |
| Linda Stacy | Principal Officer | Profile | |
| Jona Raasch | Chief Officer | Profile | |
| Jordan Freeman | Chief Officer | Profile | |
| David Burik | Executive Insights | Profile | |
| Jon Boumstein | Chief Officer | Profile | |
| Andrew Monnich | Chief Officer | Profile | |
| Helen Hrdy | Chief Officer | Profile | |
| Megan Charko | Senior Marketing | Profile | |
| Andy Monnich | Chief Officer | Profile | |
| Jason Hahn | Chief Officer | Profile | |
| Vinitha Ramnathan | Chief Officer | Profile | |
| Christophe Louvion | Chief Officer | Profile |
About National Research Management Performance
The success or failure of an entity such as National Research Corp often depends on how effective the management is. National Research management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of National management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the National management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
| Last Reported | Projected for Next Year | ||
| Return On Tangible Assets | 0.17 | 0.25 | |
| Return On Capital Employed | 0.23 | 0.37 | |
| Return On Assets | 0.09 | 0.08 | |
| Return On Equity | 0.83 | 0.52 |
Please note, the presentation of National Research's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, National Research's management is honest, while the outside auditors are strict and uncompromising. Please utilize our Beneish M Score to check the likelihood of National Research's management manipulating its earnings.
National Research Workforce Analysis
Traditionally, organizations such as National Research use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare National Research within its industry.National Research Manpower Efficiency
Return on National Research Manpower
| Revenue Per Employee | 373.3K | |
| Revenue Per Executive | 7.2M | |
| Net Income Per Employee | 31.5K | |
| Net Income Per Executive | 610.5K |
Complementary Tools for National Stock analysis
When running National Research's price analysis, check to measure National Research's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy National Research is operating at the current time. Most of National Research's value examination focuses on studying past and present price action to predict the probability of National Research's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move National Research's price. Additionally, you may evaluate how the addition of National Research to your portfolios can decrease your overall portfolio volatility.
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios |